News category:
Friday, September 22, 2017
This webinar will provide excipient users (pharmaceutical companies, contract manufacturers, and other interested stakeholders) with practical advice and information necessary in order to conduct an elemental impurity risk assessment and ultimately assure compliance with the requirements of ICH Q3D. Discover how and where to source the necessary data and information from excipient and other suppliers, including the literature, internal test results and databases.